Kelly AB - Search Results

1

Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway.

Harker LA, Hanson SR, Wilcox JN, Kelly AB. Harker LA, et al. Among authors: kelly ab. Haemostasis. 1996;26 Suppl 1:76-82. doi: 10.1159/000217245. Haemostasis. 1996. PMID: 8904178 Review.

2

Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin.

Kelly AB, Maraganore JM, Bourdon P, Hanson SR, Harker LA. Kelly AB, et al. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6040-4. doi: 10.1073/pnas.89.13.6040. Proc Natl Acad Sci U S A. 1992. PMID: 1385867 Free PMC article.

3

Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates.

Yokoyama T, Kelly AB, Marzec UM, Hanson SR, Kunitada S, Harker LA. Yokoyama T, et al. Among authors: kelly ab. Circulation. 1995 Aug 1;92(3):485-91. doi: 10.1161/01.cir.92.3.485. Circulation. 1995. PMID: 7634464

4

Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors.

Dichek DA, Anderson J, Kelly AB, Hanson SR, Harker LA. Dichek DA, et al. Among authors: kelly ab. Circulation. 1996 Jan 15;93(2):301-9. doi: 10.1161/01.cir.93.2.301. Circulation. 1996. PMID: 8548903

5

Antithrombotic benefits and hemorrhagic risks of direct thrombin antagonists.

Harker LA, Hanson SR, Kelly AB. Harker LA, et al. Among authors: kelly ab. Thromb Haemost. 1995 Jul;74(1):464-72. Thromb Haemost. 1995. PMID: 8578508 Review. No abstract available.

6

Antithrombotic strategies targeting thrombin activities, thrombin receptors and thrombin generation.

Harker LA, Hanson SR, Kelly AB. Harker LA, et al. Among authors: kelly ab. Thromb Haemost. 1997 Jul;78(1):736-41. Thromb Haemost. 1997. PMID: 9198248 Review.

7

Soluble thrombomodulin is antithrombotic in the presence of neutralising antibodies to protein C and reduces circulating activated protein C levels in primates.

Tanaka KA, Fernández JA, Marzec UM, Kelly AB, Mohri M, Griffin JH, Hanson SR, Gruber A. Tanaka KA, et al. Among authors: kelly ab. Br J Haematol. 2006 Jan;132(2):197-203. doi: 10.1111/j.1365-2141.2005.05855.x. Br J Haematol. 2006. PMID: 16398653 Free article.

8

Induction of transient neurological dysfunction in baboons by platelet microemboli.

Kessler C, Kelly AB, Suggs WD, Weissman JD, Epstein CM, Hanson SR, Harker LA. Kessler C, et al. Among authors: kelly ab. Stroke. 1992 May;23(5):697-702. doi: 10.1161/01.str.23.5.697. Stroke. 1992. PMID: 1533737

9

Antihemostatic and antithrombotic effects of monoclonal antibodies against von Willebrand factor in nonhuman primates.

Krupski WC, Bass A, Cadroy Y, Kelly AB, Harker LA, Hanson SR. Krupski WC, et al. Among authors: kelly ab. Surgery. 1992 Aug;112(2):433-9; discussion 439-40. Surgery. 1992. PMID: 1641780

10

Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon.

Hanson SR, Powell JS, Dodson T, Lumsden A, Kelly AB, Anderson JS, Clowes AW, Harker LA. Hanson SR, et al. Among authors: kelly ab. Hypertension. 1991 Oct;18(4 Suppl):II70-6. doi: 10.1161/01.hyp.18.4_suppl.ii70. Hypertension. 1991. PMID: 1833327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters